FDA-Catalyst combines direct contact with health plan members and/or providers with data included in the Sentinel Infrastructure to support FDA’s mission.

FDA-Catalyst is an important addition to surveillance and research of marketed medical products. It leverages the Sentinel Infrastructure and other capabilities of the Sentinel System to answer a wider range of questions than can be addressed by the Sentinel System data alone. These activities ultimately complement the existing post market surveillance system.